KD Logo

Tempest Therapeutics Inc (TPST) receives a Sector outperform rating from Scotiabank

Tempest Therapeutics Inc’s filing revealed that its Chief Medical Officer Whiting Samuel acquired Company’s shares for reported $9951.0 on Jul 02 ’24. In the deal valued at $2.13 per share,4,672 shares were bought. As a result of this transaction, Whiting Samuel now holds 9,573 shares worth roughly $19337.46.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Trojanowski Justin bought 7,500 shares, generating $16,200 in total proceeds. Upon buying the shares at $2.16, the Corporate Controller now owns 22,168 shares.

Scotiabank initiated its Tempest Therapeutics Inc [TPST] rating to a Sector outperform in a research note published on March 14, 2024; the price target was $13. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early February with a ‘”a Buy”‘ rating.

Price Performance Review of TPST

On Friday, Tempest Therapeutics Inc [NASDAQ:TPST] saw its stock fall -4.27% to $2.02. Over the last five days, the stock has lost -6.91%. Tempest Therapeutics Inc shares have fallen nearly -54.09% since the year began. Nevertheless, the stocks have risen 55.38% over the past one year. While a 52-week high of $9.77 was reached on 04/02/24, a 52-week low of $0.17 was recorded on 06/21/24. SMA at 50 days reached $3.05, while 200 days put it at $3.44. A total of 0.63 million shares were traded, compared to the trading of 0.39 million shares in the previous session.

Levels Of Support And Resistance For TPST Stock

The 24-hour chart illustrates a support level at 1.96, which if violated will result in even more drops to 1.91. On the upside, there is a resistance level at 2.12. A further resistance level may holdings at 2.23. The Relative Strength Index (RSI) on the 14-day chart is 24.91, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.19, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.80%. Stochastics%K at 16.87% indicates the stock is a buying.

Most Popular